Advanced search
Publication Cover
OncoImmunology Volume 1, 2012 - Issue 9
Submit an article Journal homepage
1,317
Views
74
CrossRef citations to date
0
Altmetric
Review

Trial watch

Peptide vaccines in cancer therapy

Erika Vacchelli Institut Gustave Roussy; Villejuif, France; Université Paris-Sud/Paris XI; Le Kremlin-Bicêtre, France; INSERM, U848; Villejuif, France
,
Isabelle Martins Institut Gustave Roussy; Villejuif, France; Université Paris-Sud/Paris XI; Le Kremlin-Bicêtre, France; INSERM, U848; Villejuif, France
,
Alexander Eggermont Université Paris-Sud/Paris XI; Le Kremlin-Bicêtre, France
,
Wolf Hervé Fridman Université Paris Descartes/Paris V; Sorbonne Paris Cité; Paris, France; INSERM, U872; Paris, France; Centre de Recherche des Cordeliers; Paris, France; Pôle de Biologie; Hôpital Européen Georges Pompidou; AP-HP; Paris, France
,
Jerome Galon Université Paris Descartes/Paris V; Sorbonne Paris Cité; Paris, France; INSERM, U872; Paris, France; Centre de Recherche des Cordeliers; Paris, France; Pôle de Biologie; Hôpital Européen Georges Pompidou; AP-HP; Paris, France; Université Pierre et Marie Curie/Paris VI; Paris, France
,
Catherine Sautès-Fridman Université Paris Descartes/Paris V; Sorbonne Paris Cité; Paris, France; Centre de Recherche des Cordeliers; Paris, France; Université Pierre et Marie Curie/Paris VI; Paris, France
,
Eric Tartour Pôle de Biologie; Hôpital Européen Georges Pompidou; AP-HP; Paris, France; INSERM; U970; Paris, France
,
Laurence Zitvogel INSERM, U1015; CICBT507; Villejuif, France; Université Paris-Sud/Paris XI; Le Kremlin-Bicêtre, France
,
Guido Kroemer Institut Gustave Roussy; Villejuif, France; Université Paris Descartes/Paris V; Sorbonne Paris Cité; Paris, France; Centre de Recherche des Cordeliers; Paris, France; Pôle de Biologie; Hôpital Européen Georges Pompidou; AP-HP; Paris, France; Metabolomics Platform; Institut Gustave Roussy; Villejuif, FranceCorrespondence[email protected] [email protected]
&
Lorenzo Galluzzi Institut Gustave Roussy; Villejuif, France; Université Paris Descartes/Paris V; Sorbonne Paris Cité; Paris, FranceCorrespondence[email protected] [email protected]
 show all
Pages 1557-1576 | Published online: 06 Dec 2012

Citations (74)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (34)

Assia Hijazi, Carlotta Antoniotti, Chiara Cremolini & Jérôme Galon. (2023) Light on life: immunoscore immune-checkpoint, a predictor of immunotherapy response. OncoImmunology 12:1.
Read now
Christo Kole, Nikolaos Charalampakis, Sergios Tsakatikas, Maximos Frountzas, Konstantinos Apostolou & Dimitrios Schizas. (2022) Immunotherapy in Combination with Well-Established Treatment Strategies in Pancreatic Cancer: Current Insights. Cancer Management and Research 14, pages 1043-1061.
Read now
Pauline Maby, Gabriela Bindea, Bernhard Mlecnik & Jérôme Galon. (2021) License to kill: microsatellite instability and immune contexture. OncoImmunology 10:1.
Read now
Maryam A. Shetab Boushehri, Mona M. A. Abdel-Mottaleb, Arnaud Béduneau, Yann Pellequer & Alf Lamprecht. (2018) A nanoparticle-based approach to improve the outcome of cancer active immunotherapy with lipopolysaccharides. Drug Delivery 25:1, pages 1414-1425.
Read now
Cristian Capasso, Aniket Magarkar, Victor Cervera-Carrascon, Manlio Fusciello, Sara Feola, Martin Muller, Mariangela Garofalo, Lukasz Kuryk, Siri Tähtinen, Lucio Pastore, Alex Bunker & Vincenzo Cerullo. (2017) A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma. OncoImmunology 6:9.
Read now
Luisa Circelli, Marialina Tornesello, Franco M. Buonaguro & Luigi Buonaguro. (2017) Use of adjuvants for immunotherapy. Human Vaccines & Immunotherapeutics 13:8, pages 1774-1777.
Read now
Thinle Chodon, Richard C. Koya & Kunle Odunsi. (2015) Active Immunotherapy of Cancer. Immunological Investigations 44:8, pages 817-836.
Read now
Fernando Aranda, Aitziber Buqué, Norma Bloy, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Wolf Hervé Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Adoptive cell transfer for oncological indications. OncoImmunology 4:11.
Read now
Norma Bloy, Aitziber Buqué, Fernando Aranda, Francesca Castoldi, Alexander Eggermont, Isabelle Cremer, Catherine Sautès-Fridman, Jitka Fucikova, Jérôme Galon, Radek Spisek, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial watch: Naked and vectored DNA-based anticancer vaccines. OncoImmunology 4:5.
Read now
Jonathan Pol, Norma Bloy, Aitziber Buqué, Alexander Eggermont, Isabelle Cremer, Catherine Sautès-Fridman, Jérôme Galon, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2015) Trial Watch: Peptide-based anticancer vaccines. OncoImmunology 4:4.
Read now
Erika Vacchelli, Fernando Aranda, Alexander Eggermont, Catherine Sautès-Fridman, Eric Tartour, Eugene P Kennedy, Michael Platten, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial watch: IDO inhibitors in cancer therapy. OncoImmunology 3:10.
Read now
Fernando Aranda, Erika Vacchelli, Florine Obrist, Alexander Eggermont, Jérôme Galon, Wolf Hervé Fridman, Isabelle Cremer, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:5.
Read now
Jonathan Pol, Norma Bloy, Florine Obrist, Alexander Eggermont, Jérôme Galon, Wolf Hervé Fridman, Isabelle Cremer, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:4.
Read now
Erika Vacchelli, Fernando Aranda, Alexander Eggermont, Jérôme Galon, Catherine Sautès-Fridman, Isabelle Cremer, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:3.
Read now
Fernando Aranda, Erika Vacchelli, Alexander Eggermont, Jérôme Galon, Wolf Hervé Fridman, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2014) Trial Watch. OncoImmunology 3:2.
Read now
Diana Llopiz, Eduardo Huarte, Marta Ruiz, Jaione Bezunartea, Virginia Belsúe, Aintzane Zabaleta, Juan J Lasarte, Jesús Prieto, Francisco Borrás-Cuesta & Pablo Sarobe. (2013) Helper cell-independent antitumor activity of potent CD8+ T cell epitope peptide vaccines is dependent upon CD40L. OncoImmunology 2:12.
Read now
Fernando Aranda, Erika Vacchelli, Alexander Eggermont, Jérôme Galon, Catherine Sautès-Fridman, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial Watch. OncoImmunology 2:12.
Read now
Pier-Luigi Lollini, Federica Cavallo, Carla De Giovanni & Patrizia Nanni. (2013) Preclinical vaccines against mammary carcinoma. Expert Review of Vaccines 12:12, pages 1449-1463.
Read now
Jens Bedke & Arnulf Stenzl. (2013) Immunotherapeutic strategies for the treatment of renal cell carcinoma: where are we now?. Expert Review of Anticancer Therapy 13:12, pages 1399-1408.
Read now
Michaela Semeraro, Erika Vacchelli, Alexander Eggermont , Jerome Galon, L Zitvogel, G Kroemer & Lorenzo Galluzzi. (2013) Trial Watch: Lenalidomide-based immunochemotherapy. OncoImmunology 2:11.
Read now
Erika Vacchelli, Ilio Vitale, Alexander Eggermont, Wolf Hervé Fridman, Jitka Fučíková, Isabelle Cremer, Jérôme Galon, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial watch. OncoImmunology 2:10.
Read now
Jens Bedke & Arnulf Stenzl. (2013) IMA901: a peptide vaccine in renal cell carcinoma. Expert Opinion on Investigational Drugs 22:10, pages 1329-1336.
Read now
Erika Vacchelli, Ilio Vitale, Eric Tartour, Alexander Eggermont, Catherine Sautès-Fridman, Jérôme Galon, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial Watch. OncoImmunology 2:9.
Read now
Erika Vacchelli, Alexander Eggermont, Catherine Sautès-Fridman, Jerome Galon, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial Watch. OncoImmunology 2:8.
Read now
Erika Vacchelli, Alexander Eggermont, Wolf Hervé Fridman, Jérôme Galon, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial Watch. OncoImmunology 2:7.
Read now
Erika Vacchelli, Nicole Prada, Oliver Kepp & Lorenzo Galluzzi. (2013) Current trends of anticancer immunochemotherapy. OncoImmunology 2:6.
Read now
Erika Vacchelli, Alexander Eggermont, Catherine Sautès-Fridman, Jérôme Galon, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial watch. OncoImmunology 2:6.
Read now
Erika Vacchelli, Alexander Eggermont, Wolf Hervé Fridman, Jérôme Galon, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial Watch. OncoImmunology 2:5.
Read now
Laura Senovilla, Erika Vacchelli, Pauline Garcia, Alexander Eggermont, Wolf Hervé Fridman, Jérôme Galon, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial watch. OncoImmunology 2:4.
Read now
Erika Vacchelli, Laura Senovilla, Alexander Eggermont, Wolf Hervé Fridman, Jérôme Galon, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial watch. OncoImmunology 2:3.
Read now
Lorenzo Galluzzi & Enrico Lugli. (2013) Rejuvenated T cells attack old tumors. OncoImmunology 2:2.
Read now
Laurie Menger, Erika Vacchelli, Oliver Kepp, Alexander Eggermont, Eric Tartour, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial watch. OncoImmunology 2:2.
Read now
Guido Kroemer, Laurence Zitvogel & Lorenzo Galluzzi. (2013) Victories and deceptions in tumor immunology. OncoImmunology 2:1.
Read now
Erika Vacchelli, Alexander Eggermont, Jérôme Galon, Catherine Sautès-Fridman, Laurence Zitvogel, Guido Kroemer & Lorenzo Galluzzi. (2013) Trial watch. OncoImmunology 2:1.
Read now

Articles from other publishers (40)

Bernhard Mlecnik, Alessandro Lugli, Gabriela Bindea, Florence Marliot, Carlo Bifulco, Jiun-Kae Jack Lee, Inti Zlobec, Tilman T. Rau, Martin D. Berger, Iris D. Nagtegaal, Elisa Vink-Börger, Arndt Hartmann, Carol I. Geppert, Julie Kolwelter, Susanne Merkel, Robert Grützmann, Marc Van den Eynde, Anne Jouret-Mourin, Alex Kartheuser, Daniel Léonard, Christophe Remue, Julia Wang, Prashant Bavi, Michael H. A. Roehrl, Pamela S. Ohashi, Linh T. Nguyen, SeongJun Han, Heather L. MacGregor, Sara Hafezi-Bakhtiari, Bradly G. Wouters, Giuseppe V. Masucci, Emilia K. Andersson, Eva Zavadova, Michal Vocka, Jan Spacek, Lubos Petruzelka, Bohuslav Konopasek, Pavel Dundr, Helena Skalova, Kristyna Nemejcova, Gerardo Botti, Fabiana Tatangelo, Paolo Delrio, Gennaro Ciliberto, Michele Maio, Luigi Laghi, Fabio Grizzi, Tessa Fredriksen, Bénédicte Buttard, Lucie Lafontaine, Pauline Maby, Amine Majdi, Assia Hijazi, Carine El Sissy, Amos Kirilovsky, Anne Berger, Christine Lagorce, Christopher Paustian, Carmen Ballesteros-Merino, Jeroen Dijkstra, Carlijn van de Water, Shannon van Lent-van Vliet, Nikki Knijn, Ana-Maria Mușină, Dragos-Viorel Scripcariu, Boryana Popivanova, Mingli Xu, Tomonobu Fujita, Shoichi Hazama, Nobuaki Suzuki, Hiroaki Nagano, Kiyotaka Okuno, Toshihiko Torigoe, Noriyuki Sato, Tomohisa Furuhata, Ichiro Takemasa, Prabhu Patel, Hemangini H. Vora, Birva Shah, Jayendrakumar B. Patel, Kruti N. Rajvik, Shashank J. Pandya, Shilin N. Shukla, Yili Wang, Guanjun Zhang, Yutaka Kawakami, Francesco M. Marincola, Paolo A. Ascierto, Bernard A. Fox, Franck Pagès & Jérôme Galon. (2023) Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer. Cancers 15:2, pages 418.
Crossref
Hengkai Chen, Zhenli Li, Liman Qiu, Xiuqing Dong, Geng Chen, Yingjun Shi, Linsheng Cai, Wenhan Liu, Honghao Ye, Yang Zhou, Jiahe Ouyang, Zhixiong Cai & Xiaolong Liu. (2022) Personalized neoantigen vaccine combined with PD-1 blockade increases CD8 + tissue-resident memory T-cell infiltration in preclinical hepatocellular carcinoma models . Journal for ImmunoTherapy of Cancer 10:9, pages e004389.
Crossref
Jorge Maruri, Fernando Martínez-Cortés, Josué Odales & Karen Manoutcharian. (2022) Genomic instability, origin and evolution of cancer, and personalized immunotherapy. Vacunas (English Edition) 23:3, pages 222-233.
Crossref
Jorge Maruri, Fernando Martínez-Cortés, Josué Odales & Karen Manoutcharian. (2022) Inestabilidad genética, origen y evolución del cáncer y la inmunoterapia personalizada. Vacunas 23:3, pages 222-233.
Crossref
Christo Kole, Nikolaos Charalampakis, Sergios Tsakatikas, Nikolaos-Iasonas Kouris, George Papaxoinis, Michalis V Karamouzis, Anna Koumarianou & Dimitrios Schizas. (2022) Immunotherapy for gastric cancer: a 2021 update. Immunotherapy 14:1, pages 41-64.
Crossref
Dharmendra Kumar Khatri, Jitender Madan, Kiran Jyoti & Shashi Bala Singh. 2022. Multifunctional Nanocarriers. Multifunctional Nanocarriers 347 377 .
Cao Dai Phung, Tuan Hiep Tran, Hanh Thuy Nguyen, Tien Tiep Nguyen, Jee-Heon Jeong, Sae Kwang Ku, Chul Soon Yong, Han-Gon Choi & Jong Oh Kim. (2021) Nanovaccines silencing IL-10 production at priming phase for boosting immune responses to melanoma. Journal of Controlled Release 338, pages 211-223.
Crossref
Bassel F. El-Rayes & Mehmet Akce. (2020) Immunotherapy in Pancreatic Cancer. Digestive Disease Interventions 04:04, pages 351-357.
Crossref
Daniela Bruni, Helen K. Angell & Jérôme Galon. (2020) The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy. Nature Reviews Cancer 20:11, pages 662-680.
Crossref
Christo Kole, Nikolaos Charalampakis, Sergios Tsakatikas, Michail Vailas, Dimitrios Moris, Efthymios Gkotsis, Stylianos Kykalos, Michalis V. Karamouzis & Dimitrios Schizas. (2020) Immunotherapy for Hepatocellular Carcinoma: A 2021 Update. Cancers 12:10, pages 2859.
Crossref
Dimitrios Schizas, Nikolaos Charalampakis, Christo Kole, Panagiota Economopoulou, Evangelos Koustas, Efthymios Gkotsis, Dimitrios Ziogas, Amanda Psyrri & Michalis V. Karamouzis. (2020) Immunotherapy for pancreatic cancer: A 2020 update. Cancer Treatment Reviews 86, pages 102016.
Crossref
Alexander I. Glukhov, Dmitry A. Sivokhin, Daria A. Seryak, Tatyana S. Rodionova & Margarita I. Kamynina. (2019) Oncolytic Viruses As Immunotherapeutic Agents for the Treatment of Malignant Tumors. Annals of the Russian academy of medical sciences 74:2, pages 108-117.
Crossref
Terry Medler, Jaina M. Patel, Alejandro Alice, Jason R. Baird, Hong-Ming Hu & Michael J. Gough. 2019. Nucleic Acid Sensing and Immunity, Part A. Nucleic Acid Sensing and Immunity, Part A 173 214 .
Tomohira Takeoka, Hirotsugu Nagase, Koji Kurose, Yoshihiro Ohue, Makoto Yamasaki, Shuji Takiguchi, Eiichi Sato, Midori Isobe, Takayuki Kanazawa, Mitsunobu Matsumoto, Kota Iwahori, Atsunari Kawashima, Akiko Morimoto-Okazawa, Hiroyoshi Nishikawa, Mikio Oka, Linda Pan, Ralph Venhaus, Eiichi Nakayama, Masaki Mori, Yuichiro Doki & Hisashi Wada. (2017) NY-ESO-1 Protein Cancer Vaccine With Poly-ICLC and OK-432: Rapid and Strong Induction of NY-ESO-1-specific Immune Responses by Poly-ICLC. Journal of Immunotherapy 40:4, pages 140-147.
Crossref
Daojing Yan, Ying-Wu Lin & Xiangshi Tan. (2017) Heme-containing enzymes and inhibitors for tryptophan metabolism. Metallomics 9:9, pages 1230-1240.
Crossref
Reena V. Saini & Reena Kumari. 2017. Metabolic Engineering for Bioactive Compounds. Metabolic Engineering for Bioactive Compounds 319 329 .
Larry SteinmanAmit Bar-OrJacinta M. BehneDaniel Benitez-RibasPeter S. ChinMichael Clare-SalzlerDonald HealeyJames I. KimDavid M. KranzAndreas LutterottiRoland MartinSven SchipplingPablo VillosladaCheng-Hong WeiHoward L. WeinerScott S. ZamvilMichael R. YeamanTerry J. SmithOrhan Aktas, Lilyana Amezcua, Metha Appiwatanakul, Nasrin Asgari, Brenda Banwell, Jeffrey Bennett, James Bowen, Philippe Cabre, Tanuja Chitnis, Jeffrey Cohen, Jerome De Seze, Kazuo Fujihara, May Han, Kerstin Hellwig, Rogier Hintzen, D. Craig Hooper, Raffaele Iorio, Anu Jacob, Sven Jarius, Ho Jin Kim, Najib Kissani, Eric C. Klawiter, Ingo Kleiter, Marco Lana-Peixoto, Maria Isabel Leite, Michael Levy, Fred Lublin, Yang Mao Draayer, Romain Marignier, Marcelo Matiello, Ichiro Nakashima, Kevin C. O’Connor, Jacqueline Palace, Lekha Pandit, Friedemann Paul, Naraporn Prayoonwiwat, Claire Riley, Klemens Ruprecht, Albert Saiz, Sasitorn Siritho, Silvia Tenembaum, Brian Weinshenker, Dean Wingerchuk & Jens Würfel. (2016) Restoring immune tolerance in neuromyelitis optica. Neurology Neuroimmunology & Neuroinflammation 3:5.
Crossref
Emma S. Hickman, Martine E. Lomax & Bent K. Jakobsen. (2016) Antigen Selection for Enhanced Affinity T-Cell Receptor–Based Cancer Therapies. SLAS Discovery 21:8, pages 769-785.
Crossref
Rena Morita, Yoshihiko Hirohashi, Toshihiko Torigoe, Satoko Ito-Inoda, Akari Takahashi, Tasuku Mariya, Hiroko Asanuma, Yasuaki Tamura, Tomohide Tsukahara, Takayuki Kanaseki, Terufumi Kubo, Goro Kutomi, Toru Mizuguchi, Takeshi Terui, Kunihiko Ishitani, Satoshi Hashino, Toru Kondo, Nozomi Minagawa, Norihiko Takahashi, Akinobu Taketomi, Satoru Todo, Masahiro Asaka & Noriyuki Sato. (2016) Olfactory Receptor Family 7 Subfamily C Member 1 Is a Novel Marker of Colon Cancer–Initiating Cells and Is a Potent Target of Immunotherapy. Clinical Cancer Research 22:13, pages 3298-3309.
Crossref
Burcu Temizoz, Etsushi Kuroda & Ken J. Ishii. (2016) Vaccine adjuvants as potential cancer immunotherapeutics. International Immunology 28:7, pages 329-338.
Crossref
Aurélie Hanoteau, Coralie Henin & Muriel Moser. (2016) L’immunothérapie au service de la chimiothérapie, de nouvelles avancées. médecine/sciences 32:4, pages 353-361.
Crossref
Yoshihiko Hirohashi, Toshihiko Torigoe, Tomohide Tsukahara, Takayuki Kanaseki, Vitaly Kochin & Noriyuki Sato. (2015) Immune responses to human cancer stem‐like cells/cancer‐initiating cells. Cancer Science 107:1, pages 12-17.
Crossref
Joanne Oates, Namir J. Hassan & Bent K. Jakobsen. (2015) ImmTACs for targeted cancer therapy: Why, what, how, and which. Molecular Immunology 67:2, pages 67-74.
Crossref
Jitka Fucikova, Irena Moserova, Linda Urbanova, Lucillia Bezu, Oliver Kepp, Isabelle Cremer, Cyril Salek, Pavel Strnad, Guido Kroemer, Lorenzo Galluzzi & Radek Spisek. (2015) Prognostic and Predictive Value of DAMPs and DAMP-Associated Processes in Cancer. Frontiers in Immunology 6.
Crossref
Han-Ning Huang, Venugopal Rajanbabu, Chieh-Yu Pan, Yi-Lin Chan, Jyh-Yih Chen & Chang-Jer Wu. (2015) Enhanced Control of Bladder-Associated Tumors Using Shrimp Anti-Lipopolysaccharide Factor (SALF) Antimicrobial Peptide as a Cancer Vaccine Adjuvant in Mice. Marine Drugs 13:5, pages 3241-3258.
Crossref
Mariana Aris & María Marcela Barrio. (2015) Combining Immunotherapy with Oncogene-Targeted Therapy: A New Road for Melanoma Treatment. Frontiers in Immunology 6.
Crossref
Sara Palchetti, Donatella Starace, Paola De Cesaris, Antonio Filippini, Elio Ziparo & Anna Riccioli. (2015) Transfected Poly(I:C) Activates Different dsRNA Receptors, Leading to Apoptosis or Immunoadjuvant Response in Androgen-independent Prostate Cancer Cells. Journal of Biological Chemistry 290:9, pages 5470-5483.
Crossref
Amani Makkouk, Vijaya B. Joshi, Amaraporn Wongrakpanich, Caitlin D. Lemke, Brett P. Gross, Aliasger K. Salem & George J. Weiner. (2014) Biodegradable Microparticles Loaded with Doxorubicin and CpG ODN for In Situ Immunization Against Cancer. The AAPS Journal 17:1, pages 184-193.
Crossref
Kazutaka Masuko, Daiko Wakita, Yuji Togashi, Toshiyuki Kita, Hidemitsu Kitamura & Takashi Nishimura. (2015) Artificially synthesized helper/killer-hybrid epitope long peptide (H/K-HELP): Preparation and immunological analysis of vaccine efficacy. Immunology Letters 163:1, pages 102-112.
Crossref
Xiao Liu & Justin Kline. 2015. Immunopharmacogenomics. Immunopharmacogenomics 63 84 .
Stefanie Hoyer, Sabrina Prommersberger, Isabell A. Pfeiffer, Beatrice Schuler-Thurner, Gerold Schuler, Jan Dörrie & Niels Schaft. (2014) Concurrent interaction of DCs with CD4 + and CD8 + T cells improves secondary CTL expansion: It takes three to tango . European Journal of Immunology 44:12, pages 3543-3559.
Crossref
João Conniot, Joana M. Silva, Joana G. Fernandes, Liana C. Silva, Rogério Gaspar, Steve Brocchini, Helena F. Florindo & Teresa S. Barata. (2014) Cancer immunotherapy: nanodelivery approaches for immune cell targeting and tracking. Frontiers in Chemistry 2.
Crossref
Laure Loumagne, Jeremy Baudhuin, Benoit Favier, Florent Montespan, Edgardo D. Carosella & Nathalie Rouas-Freiss. (2014) In vivo evidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance . International Journal of Cancer 135:9, pages 2107-2117.
Crossref
Laura Wayteck, Karine Breckpot, Jo Demeester, Stefaan C. De Smedt & Koen Raemdonck. (2014) A personalized view on cancer immunotherapy. Cancer Letters 352:1, pages 113-125.
Crossref
Joost PJJ Hegmans & Joachim GJV Aerts. (2014) Immunomodulation in cancer. Current Opinion in Pharmacology 17, pages 17-21.
Crossref
Steffen Rausch, Stephan Kruck, Arnulf Stenzl & Jens Bedke. (2014) IMA901 for metastatic renal cell carcinoma in the context of new approaches to immunotherapy. Future Oncology 10:6, pages 937-948.
Crossref
Jérôme Galon, Gabriela Bindea, Bernhard Mlecnik, Helen Angell, Christine Lagorce, Ana Maria Todosi, Anne Berger & Franck Pagès. (2014) Microenvironnement immunitaire et cancer. médecine/sciences 30:4, pages 439-444.
Crossref
Han-Ning Huang, Venugopal Rajanbabu, Chieh-Yu Pan, Yi-Lin Chan, Chang-Jer Wu & Jyh-Yih Chen. (2013) A cancer vaccine based on the marine antimicrobial peptide pardaxin (GE33) for control of bladder-associated tumors. Biomaterials 34:38, pages 10151-10159.
Crossref
Jérôme Galon, Helen K. Angell, Davide Bedognetti & Francesco M. Marincola. (2013) The Continuum of Cancer Immunosurveillance: Prognostic, Predictive, and Mechanistic Signatures. Immunity 39:1, pages 11-26.
Crossref
Joana M. Silva, Mafalda Videira, Rogério Gaspar, Véronique Préat & Helena F. Florindo. (2013) Immune system targeting by biodegradable nanoparticles for cancer vaccines. Journal of Controlled Release 168:2, pages 179-199.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.